Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by PoorOpinionon Mar 13, 2018 1:13pm
66 Views
Post# 27707586

RE:RE:RE:RE:RE:RE:RE:Knight to Participate in Crescita Rights Offering

RE:RE:RE:RE:RE:RE:RE:Knight to Participate in Crescita Rights Offering
rtftech16 wrote: I base my investments on a company’s financial position, not what may or might happen. Based on their balance sheet I do not feel confident investing in them more than the small amount I have in them currently 


But thats not true. You're investing in GUD based on Goodman's ability to deliver long term growth, thats definitely something that "might happen". You're "gambling" on the future. Goodman may not be at GUD long term in which case your reason for investing is dead. Isn't all investing gambling, if you want to see it that way? What you seem to be talking about is risk/reward profile, Just because GUD and ATE have very different risk/reward profiles doesnt make one a gamble and the other not a gamble.

I think most people share your long term vision for GUD, I just think they would also like to see some short term protection for there investments. We arent garenteed the perfect long term scenario, some insurance would be nice. Imagine Goodman resigns tomorrow, your raison d'etre for being in GUD is gone and the SP is weak, thats not a health spot to be in.

Its hard to argue that deal doing has been low at GUD. He doesnt have to spend the whole hoard just enough to give the impression that something is happening and that revenue is on an upward trajectory.
Bullboard Posts